(Total Views: 183)
Posted On: 01/03/2018 6:53:36 PM
Post# of 2022
NetworkNewsBreaks – EVIO, Inc. (EVIO) Appoints New President
EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning announced the appointment of Al Lustig as its new president. Reporting directly to EVIO CEO William Waldrop, Lustig’s primary responsibility in this position will be to drive the company’s growth in both new and existing markets by developing and executing national and international sales and operational strategies. “As we embark upon our next stage of rapid growth, Al’s history of recognized success in corporate growth and sales leadership at Pfizer, one of the world’s largest bio-pharmaceutical companies, makes him the perfect fit to help lead EVIO into 2018 and beyond,” Waldrop stated in the news release. “We look forward to leveraging Al’s leadership and expertise from the pharmaceutical sector. Current EVIO President and Chief Operating Officer Lori Glauser has resigned from her position as President to make room for Al in the Senior Leadership team. Ms. Glauser will remain with the company as Chief Operating Officer, leading both our advisory services division and laboratory expansion.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
EVIO, Inc. (OTCQB: EVIO), a life sciences company and leading provider of quality control testing and advisory services to the regulated cannabis industry, this morning announced the appointment of Al Lustig as its new president. Reporting directly to EVIO CEO William Waldrop, Lustig’s primary responsibility in this position will be to drive the company’s growth in both new and existing markets by developing and executing national and international sales and operational strategies. “As we embark upon our next stage of rapid growth, Al’s history of recognized success in corporate growth and sales leadership at Pfizer, one of the world’s largest bio-pharmaceutical companies, makes him the perfect fit to help lead EVIO into 2018 and beyond,” Waldrop stated in the news release. “We look forward to leveraging Al’s leadership and expertise from the pharmaceutical sector. Current EVIO President and Chief Operating Officer Lori Glauser has resigned from her position as President to make room for Al in the Senior Leadership team. Ms. Glauser will remain with the company as Chief Operating Officer, leading both our advisory services division and laboratory expansion.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Scroll down for more posts ▼
